PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1944417

PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1944417

Sacral Neuromodulation Market, By Product Type, By Application, By End User, By Patient Age Group, By Technology, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

PUBLISHED: February 26, 2026

PAGES: 374 Pages

DELIVERY TIME: 2-3 business days

ADD TO COMPARE

SELECT AN OPTION

Description

Sacral Neuromodulation market size was valued at US$ 1,987.87 Million in 2024, expanding at a CAGR of 11.51% from 2025 to 2032.

Sacral neuromodulation (SNM) works as a medical treatment that uses electrical pulses to stimulate sacral nerves. The treatment restores normal nerve function by treating abnormal nerve signals that exist between the pelvic organs and the brain. Doctors use sacral neuromodulation to treat patients who suffer from overactive bladder and urinary urge incontinence, non-obstructive urinary retention, and fecal incontinence when patients do not respond to standard treatments, which include behavioral therapy and medications. The procedure starts with a testing phase, which monitors patient response through test stimulation, before doctors implant a permanent neurostimulator system in patients who demonstrate substantial symptom relief.

Sacral Neuromodulation Market- Market Dynamics

Increased awareness and improved reimbursement pathways

The sacral neuromodulation market experiences growth because two main factors drive its expansion, since better physician and patient education result in earlier diagnosis and increased acceptance of neuromodulation therapies to treat bladder and bowel disorders. The combinationof expanded clinical training programs with stronger clinical evidence and the inclusion of sacral neuromodulation in urology and gastroenterology treatment guidelines has increased physician confidence and referral rates. The combination of clear reimbursement frameworks with expanded insurance coverage in North America and selected European markets has decreased the financial expenses that patients need to pay for device implantation and subsequent treatment. The combination of enhanced awareness with better reimbursement systems has improved patient access to treatment, which results in faster adoption of sacral neuromodulation as standard therapy for refractory conditions and drives ongoing market growth.

Sacral Neuromodulation Market- Segmentation Analysis:

By Product Type

The Implantable Pulse Generators (IPGs) segment is expected to dominate the market over the forecast period. Sacral neuromodulation systems depend on IPGs which provide controlled electrical pulses that treat pelvic floor disorders through their direct connection to sacral nerves. The IPG devices serve as essential components for therapy operations which creates a direct link between their market demand and the adoption of sacral neuromodulation treatments that generate substantial revenue in the entire industry market. The ongoing development of technology through smaller device designs, extended battery operation, MRI compatibility, and programmable capabilities has made IPGs more beneficial for patients and doctors. The improvements lead to better patient comfort, which results in better clinical outcomes, and this effect increases both usage rates and product repurchases.

Sacral Neuromodulation Market- Geographical Insights

North America is expected to dominate the Sacral Neuromodulation market during the forecast period. The main reason for growth comes from the high occurrence of urinary and fecal incontinence, together with other pelvic floor disorders, which create a continuous need for effective neuromodulation treatments. The region enjoys benefits from its strong healthcare network, which provides multiple medical facilities that offer advanced treatment options and operate under established clinical methods for treating patients through procedures like sacral nerve stimulation. The United States and Canada now provide better reimbursement systems together with expanded insurance coverage, which reduces financial barriers that patients and healthcare facilities face, thereby increasing the availability and economic feasibility of sacral neuromodulation as a treatment option. The presence of major device manufacturers together with ongoing technological advancements in neuromodulation systems has led to the creation of better implantable devices that feature extended battery life and advanced programming functions, which help doctors choose these devices while patients become more willing to accept them, thus driving revenue growth in the North American market.

Sacral Neuromodulation Market- Competitive Landscape:

The sacral neuromodulation market functions through intense competition, which three major medtech companies Medtronic Axonics and Boston Scientific control while other established companies, including Abbott and various regional device manufacturers, compete. The market competition arises through three main factors which include technology differences that involve smaller MRI-safe rechargeable-free implantable pulse generators, better leads and programming software and the strength of distribution and clinical support, which helps doctors adopt new technologies. The current market environment results from legal and IP contests that have occurred between companies, while recent court decisions and active disputes have changed market competition and access. The market distribution keeps changing through ongoing product approvals, targeted M&A activities and strategic partnerships, while fast-growing Asian markets have become accessible for both agile competitors and local businesses to operate.

Recent Developments:

In June 2025, Neuspera(R) Medical, Inc., the leading developer of integrated technologies powering the future of neuromodulation, announced that the U.S. Food and Drug Administration (FDA) has approved its integrated sacral neuromodulation (iSNM) system for the treatment of urinary urge incontinence (UUI).

In May 2025, Medtronic launched its next-generation InterStim X system featuring advanced wireless programming capabilities and extended battery life, significantly improving patient convenience and treatment outcomes.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SACRAL NEUROMODULATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

BioControl Medical
Uroplasty Inc.
Cogentix Medical Inc.
Cyberonics Inc.
Nuvectra Corporation
Nevro Corp.
Synapse Biomedical Inc.
ImThera Medical Inc.
Abbott Laboratories
Advanced Bionics AG
Stryker Corporation
Inspire Medical Systems Inc.
Laborie Medical Technologies
MicroTransponder Inc.
Brainsway Ltd.
EndoStim Inc.
Stimwave LLC

GLOBAL SACRAL NEUROMODULATION MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

External/Non-Implantable Pulse Generators (EPGs)
Lead Electrodes
Implantable Pulse Generators (IPGs)
Accessories and System Components

GLOBAL SACRAL NEUROMODULATION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Urinary Incontinence
Urinary Retention
Fecal Incontinence
Overactive Bladder
Chronic Pelvic Pain and Relative Pelvic Pain
Others

GLOBAL SACRAL NEUROMODULATION MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

Hospitals and Large Medical Centers
Ambulatory Surgical Centers
Specialty Clinics
Research and Academic Institutes

GLOBAL SACRAL NEUROMODULATION MARKET, BY PATIENT AGE GROUP- MARKET ANALYSIS, 2019 - 2032

Adult
Pediatric
Geriatric

GLOBAL SACRAL NEUROMODULATION MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

Rechargeable Systems
Non-Rechargeable Systems
Wired/Lead Systems vs Wireless/Leadless Systems
Trial Systems vs Permanent Systems

GLOBAL SACRAL NEUROMODULATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV5985

1. Sacral Neuromodulation Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Sacral Neuromodulation Market Snippet by Product Type
- 2.1.2. Sacral Neuromodulation Market Snippet by Application
- 2.1.3. Sacral Neuromodulation Market Snippet by End User
- 2.1.4. Sacral Neuromodulation Market Snippet by Patient Age Group
- 2.1.5. Sacral Neuromodulation Market Snippet by Technology
- 2.1.6. Sacral Neuromodulation Market Snippet by Country
- 2.1.7. Sacral Neuromodulation Market Snippet by Region
2.2. Competitive Insights

3. Sacral Neuromodulation Key Market Trends

3.1. Sacral Neuromodulation Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Sacral Neuromodulation Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Sacral Neuromodulation Market Opportunities
3.4. Sacral Neuromodulation Market Future Trends

4. Sacral Neuromodulation Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Sacral Neuromodulation Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Sacral Neuromodulation Market Landscape

6.1. Sacral Neuromodulation Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Sacral Neuromodulation Market - By Product Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
- 7.1.2. External/Non-Implantable Pulse Generators (EPGs)
- 7.1.3. Lead Electrodes
- 7.1.4. Implantable Pulse Generators (IPGs)
- 7.1.5. Accessories and System Components

8. Sacral Neuromodulation Market - By Application

8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 8.1.2. Urinary Incontinence
- 8.1.3. Urinary Retention
- 8.1.4. Fecal Incontinence
- 8.1.5. Overactive Bladder
- 8.1.6. Chronic Pelvic Pain and Relative Pelvic Pain
- 8.1.7. Others

9. Sacral Neuromodulation Market - By End User

9.1. Overview
- 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
- 9.1.2. Hospitals and Large Medical Centers
- 9.1.3. Ambulatory Surgical Centers
- 9.1.4. Specialty Clinics
- 9.1.5. Research and Academic Institutes

10. Sacral Neuromodulation Market - By Patient Age Group

10.1. Overview
- 10.1.1. Segment Share Analysis, By Patient Age Group, 2024 & 2032 (%)
- 10.1.2. Adult
- 10.1.3. Pediatric
- 10.1.4. Geriatric

11. Sacral Neuromodulation Market - By Technology

11.1. Overview
- 11.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
- 11.1.2. Rechargeable Systems
- 11.1.3. Non-Rechargeable Systems
- 11.1.4. Wired/Lead Systems vs Wireless/Leadless Systems
- 11.1.5. Trial Systems vs Permanent Systems

12. Sacral Neuromodulation Market- By Geography

12.1. Introduction
- 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
12.2. North America
- 12.2.1. Overview
- 12.2.2. Sacral Neuromodulation Key Manufacturers in North America
- 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.2.7. North America Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
- 12.2.8. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.2.9. U.S.
  - 12.2.9.1. Overview
  - 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.2.9.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.2.9.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.2.9.6. U.S. Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.2.9.7. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.2.10. Canada
  - 12.2.10.1. Overview
  - 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.2.10.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.2.10.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.2.10.6. Canada Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.2.10.7. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3. Europe
- 12.3.1. Overview
- 12.3.2. Sacral Neuromodulation Key Manufacturers in Europe
- 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.7. Europe Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
- 12.3.8. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.3.9. Germany
  - 12.3.9.1. Overview
  - 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.9.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.9.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.3.9.6. Germany Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.3.9.7. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.3.10. UK
  - 12.3.10.1. Overview
  - 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.10.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.10.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.3.10.6. UK Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.3.10.7. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.3.11. France
  - 12.3.11.1. Overview
  - 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.11.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.11.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.3.11.6. France Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.3.11.7. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.3.12. Italy
  - 12.3.12.1. Overview
  - 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.12.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.12.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.3.12.6. Italy Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.3.12.7. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.3.13. Spain
  - 12.3.13.1. Overview
  - 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.13.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.13.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.3.13.6. Spain Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.3.13.7. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.3.14. The Netherlands
  - 12.3.14.1. Overview
  - 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.14.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.14.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.3.14.6. The Netherlands Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.3.14.7. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.3.15. Sweden
  - 12.3.15.1. Overview
  - 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.15.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.15.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.3.15.6. Sweden Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.3.15.7. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.3.16. Russia
  - 12.3.16.1. Overview
  - 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.16.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.16.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.3.16.6. Russia Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.3.16.7. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.3.17. Poland
  - 12.3.17.1. Overview
  - 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.17.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.17.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.3.17.6. Poland Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.3.17.7. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.3.18. Rest of Europe
  - 12.3.18.1. Overview
  - 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.18.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.18.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.3.18.6. Rest of the Europe Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.3.18.7. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
- 12.4.1. Overview
- 12.4.2. Sacral Neuromodulation Key Manufacturers in Asia Pacific
- 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.7. APAC Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
- 12.4.8. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.4.9. China
  - 12.4.9.1. Overview
  - 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.9.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.9.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.4.9.6. China Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.4.9.7. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.4.10. India
  - 12.4.10.1. Overview
  - 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.10.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.10.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.4.10.6. India Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.4.10.7. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.4.11. Japan
  - 12.4.11.1. Overview
  - 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.11.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.11.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.4.11.6. Japan Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.4.11.7. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.4.12. South Korea
  - 12.4.12.1. Overview
  - 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.12.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.12.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.4.12.6. South Korea Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.4.12.7. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.4.13. Australia
  - 12.4.13.1. Overview
  - 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.13.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.13.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.4.13.6. Australia Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.4.13.7. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.4.14. Indonesia
  - 12.4.14.1. Overview
  - 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.14.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.14.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.4.14.6. Indonesia Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.4.14.7. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.4.15. Thailand
  - 12.4.15.1. Overview
  - 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.15.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.15.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.4.15.6. Thailand Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.4.15.7. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.4.16. Philippines
  - 12.4.16.1. Overview
  - 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.16.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.16.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.4.16.6. Philippines Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.4.16.7. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.4.17. Rest of APAC
  - 12.4.17.1. Overview
  - 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.17.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.4.17.6. Rest of APAC Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.4.17.7. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5. Latin America (LATAM)
- 12.5.1. Overview
- 12.5.2. Sacral Neuromodulation Key Manufacturers in Latin America
- 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.7. LATAM Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
- 12.5.8. LATAM Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.5.9. Brazil
  - 12.5.9.1. Overview
  - 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.9.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.9.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.5.9.6. Brazil Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.5.9.7. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.5.10. Mexico
  - 12.5.10.1. Overview
  - 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.10.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.10.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.5.10.6. Mexico Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.5.10.7. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.5.11. Argentina
  - 12.5.11.1. Overview
  - 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.11.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.11.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.5.11.6. Argentina Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.5.11.7. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.5.12. Colombia
  - 12.5.12.1. Overview
  - 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.12.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.12.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.5.12.6. Colombia Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.5.12.7. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.5.13. Rest of LATAM
  - 12.5.13.1. Overview
  - 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.13.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.13.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.5.13.6. Rest of LATAM Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.5.13.7. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
- 12.6.1. Overview
- 12.6.2. Sacral Neuromodulation Key Manufacturers in Middle East and Africa
- 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.7. Middle East and Africa Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
- 12.6.8. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.6.9. Saudi Arabia
  - 12.6.9.1. Overview
  - 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.9.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.9.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.6.9.6. Saudi Arabia Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.6.9.7. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.6.10. United Arab Emirates
  - 12.6.10.1. Overview
  - 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.10.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.10.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.6.10.6. United Arab Emirates Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.6.10.7. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.6.11. Israel
  - 12.6.11.1. Overview
  - 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.11.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.11.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.6.11.6. Israel Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.6.11.7. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.6.12. Turkey
  - 12.6.12.1. Overview
  - 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.12.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.12.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.6.12.6. Turkey Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.6.12.7. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.6.13. Algeria
  - 12.6.13.1. Overview
  - 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.13.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.13.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.6.13.6. Algeria Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.6.13.7. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.6.14. Egypt
  - 12.6.14.1. Overview
  - 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.14.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.14.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.6.14.6. Egypt Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.6.14.7. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 12.6.15. Rest of MEA
  - 12.6.15.1. Overview
  - 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.15.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  - 12.6.15.6. Rest of MEA Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
  - 12.6.15.7. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Sacral Neuromodulation Industry

13.1. Competitive Benchmarking
- 13.1.1. Competitive Dashboard
- 13.1.2. Competitive Positioning
13.2. Company Profiles
- 13.2.1. BioControl Medical
- 13.2.2. Uroplasty Inc.
- 13.2.3. Cogentix Medical Inc.
- 13.2.4. Cyberonics Inc.
- 13.2.5. Nuvectra Corporation
- 13.2.6. Nevro Corp.
- 13.2.7. Synapse Biomedical Inc.
- 13.2.8. ImThera Medical Inc.
- 13.2.9. Abbott Laboratories
- 13.2.10. Advanced Bionics AG
- 13.2.11. Stryker Corporation
- 13.2.12. Inspire Medical Systems Inc.
- 13.2.13. Laborie Medical Technologies
- 13.2.14. MicroTransponder Inc.
- 13.2.15. Brainsway Ltd.
- 13.2.16. EndoStim Inc.
- 13.2.17. Stimwave LLC

14. 360 Degree Analyst View

15. Appendix

15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us

Have a question?

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Christine Sirois

Manager - Americas

+1-860-674-8796

SEE OUR FAQ